https://www.selleckchem.com/pr....oducts/monomethyl-au
Treatment was discontinued in two patients with interstitial pneumonia, but no deaths were encountered. During the maintenance phase, one patient needed dose reductions due to phlegmon. No significant difference in efficacy was seen between PS 0 and PS 1. Carboplatin and pemetrexed followed by maintenance pemetrexed for non-squamous non-small cell lung cancer in elderly patients appear effective and tolerable. Carboplatin and pemetrexed followed by maintenance pemetrexed for non-squamous non-small cell lung cancer i
Like
Comment
Share
